CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: NEWBORN SCREENING MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Instrument
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Consumables
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: NEWBORN SCREENING MARKET, BY TEST TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Blood test
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Hearing screening test
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Heart screening
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: NEWBORN SCREENING MARKET, BY TECHNOLOGY
6.1 Overview
6.1.1 Market size and forecast
6.2 Tandem Mass Spectrometry (TMS)
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Molecular Assays
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Immunoassays and Enzymatic Assays
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Hearing Screen Technology
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Pulse Oximetry Screening Technology
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
6.7 Others
6.7.1 Key market trends, growth factors and opportunities
6.7.2 Market size and forecast, by region
6.7.3 Market analysis by country
CHAPTER 7: NEWBORN SCREENING MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospitals
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Clinical laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
CHAPTER 8: NEWBORN SCREENING MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product Type
8.2.3 North America Market size and forecast, by Test Type
8.2.4 North America Market size and forecast, by Technology
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product Type
8.2.6.1.2 Market size and forecast, by Test Type
8.2.6.1.3 Market size and forecast, by Technology
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product Type
8.2.6.2.2 Market size and forecast, by Test Type
8.2.6.2.3 Market size and forecast, by Technology
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product Type
8.2.6.3.2 Market size and forecast, by Test Type
8.2.6.3.3 Market size and forecast, by Technology
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product Type
8.3.3 Europe Market size and forecast, by Test Type
8.3.4 Europe Market size and forecast, by Technology
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product Type
8.3.6.1.2 Market size and forecast, by Test Type
8.3.6.1.3 Market size and forecast, by Technology
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product Type
8.3.6.2.2 Market size and forecast, by Test Type
8.3.6.2.3 Market size and forecast, by Technology
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Product Type
8.3.6.3.2 Market size and forecast, by Test Type
8.3.6.3.3 Market size and forecast, by Technology
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product Type
8.3.6.4.2 Market size and forecast, by Test Type
8.3.6.4.3 Market size and forecast, by Technology
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product Type
8.3.6.5.2 Market size and forecast, by Test Type
8.3.6.5.3 Market size and forecast, by Technology
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product Type
8.3.6.6.2 Market size and forecast, by Test Type
8.3.6.6.3 Market size and forecast, by Technology
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product Type
8.4.3 Asia-Pacific Market size and forecast, by Test Type
8.4.4 Asia-Pacific Market size and forecast, by Technology
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product Type
8.4.6.1.2 Market size and forecast, by Test Type
8.4.6.1.3 Market size and forecast, by Technology
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product Type
8.4.6.2.2 Market size and forecast, by Test Type
8.4.6.2.3 Market size and forecast, by Technology
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Product Type
8.4.6.3.2 Market size and forecast, by Test Type
8.4.6.3.3 Market size and forecast, by Technology
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Product Type
8.4.6.4.2 Market size and forecast, by Test Type
8.4.6.4.3 Market size and forecast, by Technology
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product Type
8.4.6.5.2 Market size and forecast, by Test Type
8.4.6.5.3 Market size and forecast, by Technology
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product Type
8.4.6.6.2 Market size and forecast, by Test Type
8.4.6.6.3 Market size and forecast, by Technology
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product Type
8.5.3 LAMEA Market size and forecast, by Test Type
8.5.4 LAMEA Market size and forecast, by Technology
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product Type
8.5.6.1.2 Market size and forecast, by Test Type
8.5.6.1.3 Market size and forecast, by Technology
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product Type
8.5.6.2.2 Market size and forecast, by Test Type
8.5.6.2.3 Market size and forecast, by Technology
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product Type
8.5.6.3.2 Market size and forecast, by Test Type
8.5.6.3.3 Market size and forecast, by Technology
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product Type
8.5.6.4.2 Market size and forecast, by Test Type
8.5.6.4.3 Market size and forecast, by Technology
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Ab Sciex LLC
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Agilent Technologies Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Bio-Rad Laboratories Inc.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Covidien Plc
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Ge Healthcare
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 PERKINELMER, INC.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 MASIMO CORPORATION
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Natus Medical Incorporated
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Trivitron Healthcare
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Waters Corporation
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
TABLE 1. GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 2. NEWBORN SCREENING MARKET REVENUE, FOR INSTRUMENT, BY REGION , 2021-2031,($MILLION)
TABLE 3. NEWBORN SCREENING MARKET FOR INSTRUMENT BY COUNTRY, 2021-2031,($MILLION)
TABLE 4. NEWBORN SCREENING MARKET REVENUE, FOR CONSUMABLES, BY REGION , 2021-2031,($MILLION)
TABLE 5. NEWBORN SCREENING MARKET FOR CONSUMABLES BY COUNTRY, 2021-2031,($MILLION)
TABLE 6. GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 7. NEWBORN SCREENING MARKET REVENUE, FOR BLOOD TEST, BY REGION , 2021-2031,($MILLION)
TABLE 8. NEWBORN SCREENING MARKET FOR BLOOD TEST BY COUNTRY, 2021-2031,($MILLION)
TABLE 9. NEWBORN SCREENING MARKET REVENUE, FOR HEARING SCREENING TEST, BY REGION , 2021-2031,($MILLION)
TABLE 10. NEWBORN SCREENING MARKET FOR HEARING SCREENING TEST BY COUNTRY, 2021-2031,($MILLION)
TABLE 11. NEWBORN SCREENING MARKET REVENUE, FOR HEART SCREENING, BY REGION , 2021-2031,($MILLION)
TABLE 12. NEWBORN SCREENING MARKET FOR HEART SCREENING BY COUNTRY, 2021-2031,($MILLION)
TABLE 13. GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 14. NEWBORN SCREENING MARKET REVENUE, FOR TANDEM MASS SPECTROMETRY (TMS), BY REGION , 2021-2031,($MILLION)
TABLE 15. NEWBORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY (TMS) BY COUNTRY, 2021-2031,($MILLION)
TABLE 16. NEWBORN SCREENING MARKET REVENUE, FOR MOLECULAR ASSAYS, BY REGION , 2021-2031,($MILLION)
TABLE 17. NEWBORN SCREENING MARKET FOR MOLECULAR ASSAYS BY COUNTRY, 2021-2031,($MILLION)
TABLE 18. NEWBORN SCREENING MARKET REVENUE, FOR IMMUNOASSAYS AND ENZYMATIC ASSAYS, BY REGION , 2021-2031,($MILLION)
TABLE 19. NEWBORN SCREENING MARKET FOR IMMUNOASSAYS AND ENZYMATIC ASSAYS BY COUNTRY, 2021-2031,($MILLION)
TABLE 20. NEWBORN SCREENING MARKET REVENUE, FOR HEARING SCREEN TECHNOLOGY, BY REGION , 2021-2031,($MILLION)
TABLE 21. NEWBORN SCREENING MARKET FOR HEARING SCREEN TECHNOLOGY BY COUNTRY, 2021-2031,($MILLION)
TABLE 22. NEWBORN SCREENING MARKET REVENUE, FOR PULSE OXIMETRY SCREENING TECHNOLOGY, BY REGION , 2021-2031,($MILLION)
TABLE 23. NEWBORN SCREENING MARKET FOR PULSE OXIMETRY SCREENING TECHNOLOGY BY COUNTRY, 2021-2031,($MILLION)
TABLE 24. NEWBORN SCREENING MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
TABLE 25. NEWBORN SCREENING MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 26. GLOBAL NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 27. NEWBORN SCREENING MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
TABLE 28. NEWBORN SCREENING MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
TABLE 29. NEWBORN SCREENING MARKET REVENUE, FOR CLINICAL LABORATORIES, BY REGION , 2021-2031,($MILLION)
TABLE 30. NEWBORN SCREENING MARKET FOR CLINICAL LABORATORIES BY COUNTRY, 2021-2031,($MILLION)
TABLE 31. NEWBORN SCREENING MARKET, BY REGION, 2021-2031,($MILLION)
TABLE 32. NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 33. NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 34. NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 35. NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 36. NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 37. U.S. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 38. U.S. NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 39. U.S. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 40. U.S. NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 41. CANADA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 42. CANADA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 43. CANADA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 44. CANADA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 45. MEXICO NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 46. MEXICO NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 47. MEXICO NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 48. MEXICO NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 49. EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 50. EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 51. EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 52. EUROPE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 53. EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 54. GERMANY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 55. GERMANY NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 56. GERMANY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 57. GERMANY NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 58. FRANCE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 59. FRANCE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 60. FRANCE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 61. FRANCE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 62. U.K. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 63. U.K. NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 64. U.K. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 65. U.K. NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 66. ITALY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 67. ITALY NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 68. ITALY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 69. ITALY NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 70. SPAIN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 71. SPAIN NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 72. SPAIN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 73. SPAIN NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 74. REST OF EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 75. REST OF EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 76. REST OF EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 77. REST OF EUROPE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 78. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 79. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 80. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 81. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 82. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 83. JAPAN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 84. JAPAN NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 85. JAPAN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 86. JAPAN NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 87. CHINA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 88. CHINA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 89. CHINA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 90. CHINA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 91. AUSTRALIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 92. AUSTRALIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 93. AUSTRALIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 94. AUSTRALIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 95. INDIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 96. INDIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 97. INDIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 98. INDIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 99. SOUTH KOREA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 100. SOUTH KOREA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 101. SOUTH KOREA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 102. SOUTH KOREA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 103. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 104. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 105. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 106. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 107. LAMEA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 108. LAMEA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 109. LAMEA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 110. LAMEA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 111. LAMEA NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 112. BRAZIL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 113. BRAZIL NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 114. BRAZIL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 115. BRAZIL NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 116. SAUDI ARABIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 117. SAUDI ARABIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 118. SAUDI ARABIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 119. SAUDI ARABIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 120. SOUTH AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 121. SOUTH AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 122. SOUTH AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 123. SOUTH AFRICA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 124. REST OF LAMEA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 125. REST OF LAMEA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 126. REST OF LAMEA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 127. REST OF LAMEA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 128.AB SCIEX LLC: COMPANY SNAPSHOT
TABLE 129.AB SCIEX LLC: OPERATING SEGMENTS
TABLE 130.AB SCIEX LLC: PRODUCT PORTFOLIO
TABLE 131.AB SCIEX LLC: NET SALES,
TABLE 132.AB SCIEX LLC: KEY STRATERGIES
TABLE 133.AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 134.AGILENT TECHNOLOGIES INC.: OPERATING SEGMENTS
TABLE 135.AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 136.AGILENT TECHNOLOGIES INC.: NET SALES,
TABLE 137.AGILENT TECHNOLOGIES INC.: KEY STRATERGIES
TABLE 138.BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
TABLE 139.BIO-RAD LABORATORIES INC.: OPERATING SEGMENTS
TABLE 140.BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 141.BIO-RAD LABORATORIES INC.: NET SALES,
TABLE 142.BIO-RAD LABORATORIES INC.: KEY STRATERGIES
TABLE 143.COVIDIEN PLC: COMPANY SNAPSHOT
TABLE 144.COVIDIEN PLC: OPERATING SEGMENTS
TABLE 145.COVIDIEN PLC: PRODUCT PORTFOLIO
TABLE 146.COVIDIEN PLC: NET SALES,
TABLE 147.COVIDIEN PLC: KEY STRATERGIES
TABLE 148.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 149.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 150.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 151.GE HEALTHCARE: NET SALES,
TABLE 152.GE HEALTHCARE: KEY STRATERGIES
TABLE 153.PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 154.PERKINELMER, INC.: OPERATING SEGMENTS
TABLE 155.PERKINELMER, INC.: PRODUCT PORTFOLIO
TABLE 156.PERKINELMER, INC.: NET SALES,
TABLE 157.PERKINELMER, INC.: KEY STRATERGIES
TABLE 158.MASIMO CORPORATION: COMPANY SNAPSHOT
TABLE 159.MASIMO CORPORATION: OPERATING SEGMENTS
TABLE 160.MASIMO CORPORATION: PRODUCT PORTFOLIO
TABLE 161.MASIMO CORPORATION: NET SALES,
TABLE 162.MASIMO CORPORATION: KEY STRATERGIES
TABLE 163.NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 164.NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
TABLE 165.NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 166.NATUS MEDICAL INCORPORATED: NET SALES,
TABLE 167.NATUS MEDICAL INCORPORATED: KEY STRATERGIES
TABLE 168.TRIVITRON HEALTHCARE: COMPANY SNAPSHOT
TABLE 169.TRIVITRON HEALTHCARE: OPERATING SEGMENTS
TABLE 170.TRIVITRON HEALTHCARE: PRODUCT PORTFOLIO
TABLE 171.TRIVITRON HEALTHCARE: NET SALES,
TABLE 172.TRIVITRON HEALTHCARE: KEY STRATERGIES
TABLE 173.WATERS CORPORATION: COMPANY SNAPSHOT
TABLE 174.WATERS CORPORATION: OPERATING SEGMENTS
TABLE 175.WATERS CORPORATION: PRODUCT PORTFOLIO
TABLE 176.WATERS CORPORATION: NET SALES,
TABLE 177.WATERS CORPORATION: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/